Secondary parkinsonism.
Terashi H, Taguchi T, Aizawa H.
Nihon Rinsho. 2017 Jan;75(1):63-70.
Secondary parkinsonism due to drugs, vascular lesions, tumors, trauma, and other insults.
Höllerhage M.
Int Rev Neurobiol. 2019;149:377-418. doi: 10.1016/bs.irn.2019.10.010. Epub 2019 Nov 21.
Nonmotor Symptoms in Vascular and Other Secondary Parkinsonism.
Levin OS, Chimagomedova AS, Skripkina NA, Lyashenko EA, Babkina OV.
Int Rev Neurobiol. 2017;134:1303-1334. doi: 10.1016/bs.irn.2017.05.016. Epub 2017 Jul 4.
The diagnosis of Parkinson's disease.
Tolosa E, Wenning G, Poewe W.
Lancet Neurol. 2006 Jan;5(1):75-86. doi: 10.1016/S1474-4422(05)70285-4.
Parkinsonism secondary to neurosyphilis.
Carr J.
Mov Disord. 2009 Jul 15;24(9):1407. doi: 10.1002/mds.22615.
Parkinsonism secondary to neurosyphilis.
Spitz M, Maia FM, Gomes HR, Scaff M, Barbosa ER.
Mov Disord. 2008 Oct 15;23(13):1948-9. doi: 10.1002/mds.22171.
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
Langston JW, Ballard P, Tetrud JW, Irwin I.
Science. 1983 Feb 25;219(4587):979-80. doi: 10.1126/science.6823561.
Secondary parkinsonism with Mumps infection.
Abbas MM, Basu P, Reginald V, Kumar RH, Muthane UB.
Parkinsonism Relat Disord. 2015 Oct;21(10):1288-9. doi: 10.1016/j.parkreldis.2015.08.028. Epub 2015 Aug 28.
Autoimmune-mediated secondary-parkinsonism presented with micrographia and cognitive impairment.
Che NN, Chen SY, Li X, Ma JJ, Yang HQ.
J Neuroimmunol. 2021 Dec 15;361:577738. doi: 10.1016/j.jneuroim.2021.577738. Epub 2021 Oct 5.
[Drug-induced parkinsonism].
Ory-Magne F.
Rev Prat. 2020 May;70(5):475-478.
